Pramlintide: Phase II data

Data from a placebo-controlled, dose-escalation, U.S. Phase II trial in

Read the full 107 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE